Cargando…
GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
BACKGROUND: Although many biomarkers have been reported for detecting glioma, the prognosis for the disease remains poor, and therefore, new biomarkers need to be identified. GNG5, which is part of the G-protein family, has been associated with different malignant tumors, though the role of GNG5 in...
Autores principales: | Zhang, Wang, Liu, Zhendong, Liu, Binchao, Jiang, Miaomiao, Yan, Shi, Han, Xian, Shen, Hong, Na, Meng, Wang, Yanbiao, Ren, Zhishuai, Liu, Binfeng, Jiang, Zhenfeng, Gao, Yanzheng, Lin, Zhiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186147/ https://www.ncbi.nlm.nih.gov/pubmed/34098960 http://dx.doi.org/10.1186/s12935-021-01935-7 |
Ejemplares similares
-
GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022) -
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021) -
Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022) -
Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021) -
Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)